Literature DB >> 19734081

Validation of a simple index (SIisOGTT) of insulin sensitivity in a population of sedentary men.

E Pigeon1, M E Riou, J St-Onge, E Couillard, A Tremblay, A Marette, S J Weisnagel, D R Joanisse.   

Abstract

AIM: The ongoing obesity epidemic is associated with numerous health problems related to altered metabolic function. Among these is type 2 diabetes, characterized by lowered insulin sensitivity (IS). Consequently, the development of simple indices to assess IS has research and clinical importance. The SI(is)OGTT, a new index of IS, was recently described by Bastard et al. (Diabetes & Metabolism 2007;33:261-8), and validated in sedentary, non-diabetic, overweight and obese postmenopausal women. The aim of the present study was to validate the index in men.
METHODS: The data used in this project came from sedentary men (n=36), aged 34-53 years, all of whom underwent a hyperinsulinaemic-euglycaemic clamp and 2-hour oral glucose tolerance test (OGTT). Correlations with M/I (glucose infusion rate [GIR] divided by insulin concentration), GIR and GIR divided by fat-free mass (FFM) were obtained by four well-known indices (HOMA, QUICKI, Cederholm and Matsuda) as well as with the new SI(is)OGTT index. Pearson correlations and Bland-Altman analyses were obtained for every index versus clamp value.
RESULTS: The best correlate of IS in the present study was the SI(is)OGTT (r=0.84, P<0.0001). The agreement of this method with the hyperinsulinaemic-euglycaemic clamp, as assessed by Bland-Altman plots, was similar to those of the other indices and to those previously described in postmenopausal women.
CONCLUSION: The new index proposed by Bastard et al. is as good a predictor of IS in sedentary men as the other commonly used indices, and appears to be as reliable in this population as it was in the original study of postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734081     DOI: 10.1016/j.diabet.2009.04.007

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  6 in total

1.  Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story? Reply to Bastard JP, Rabasa-Lhoret R, Laville M and Disse E [letter].

Authors:  Julia Otten; Bo Ahrén; Tommy Olsson
Journal:  Diabetologia       Date:  2014-11-22       Impact factor: 10.122

2.  Irisin is more strongly predicted by muscle oxidative potential than adiposity in non-diabetic men.

Authors:  Claire Huth; Marie-Julie Dubois; André Marette; Angelo Tremblay; S John Weisnagel; Michel Lacaille; Pascale Mauriège; Denis R Joanisse
Journal:  J Physiol Biochem       Date:  2015-03-28       Impact factor: 4.158

3.  Fitness, adiposopathy, and adiposity are independent predictors of insulin sensitivity in middle-aged men without diabetes.

Authors:  Claire Huth; Étienne Pigeon; Marie-Ève Riou; Josée St-Onge; Hélène Arguin; Erick Couillard; Marie-Julie Dubois; André Marette; Angelo Tremblay; S John Weisnagel; Michel Lacaille; Pascale Mauriège; Denis R Joanisse
Journal:  J Physiol Biochem       Date:  2016-05-02       Impact factor: 4.158

Review 4.  Selection of the appropriate method for the assessment of insulin resistance.

Authors:  Anwar Borai; Callum Livingstone; Ibrahim Kaddam; Gordon Ferns
Journal:  BMC Med Res Methodol       Date:  2011-11-23       Impact factor: 4.615

5.  Sex-related differences in the effects of the mediterranean diet on glucose and insulin homeostasis.

Authors:  Alexandra Bédard; Louise Corneau; Benoît Lamarche; Sylvie Dodin; Simone Lemieux
Journal:  J Nutr Metab       Date:  2014-10-09

6.  Combined aerobic and resistance training: are there additional benefits for older hypertensive adults?

Authors:  Leandra G Lima; José T M Bonardi; Giulliard O Campos; Rodrigo F Bertani; Luria M L Scher; Júlio C Moriguti; Eduardo Ferriolli; Nereida K C Lima
Journal:  Clinics (Sao Paulo)       Date:  2017-06       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.